Close
Nordic 9Nordic 9

Danaher Life Sciences (investor - Corporate Investor)

United States danaher.com
See something wrong or missing? Let us know
Offices:Washington

Danaher is a Fortune 500 science and technology innovator helping solve complex challenges, and improving quality of life around the world.

Average round investment:107.42M USD
Average number per year:1.0
Distribution: 2021 (1)2020 (1)
Portfolio companies: France DNA Script
Mostly invests in: France France (2) Health services (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Danaher Life Sciences

Name Criteria
United States ArrowMark Partners
63%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Redmile Group
63%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Agilent Technologies
63%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Emerson Collective
63%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Illumina Accelerator
63%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Leonard Green & Partners L.P.
63%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Columbia Threadneedle Investments
63%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Merieux Equity Partners
62%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Farallon Capital Management
62%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Catalio Capital Management
61%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top